Clearance of Alzheimer's Abeta peptide: the many roads to perdition

Neuron
R E TanziS L Wagner

Abstract

The amyloid hypothesis of Alzheimer's disease (AD) maintains that the accumulation of the amyloid beta protein (Abeta) is a critical event in disease pathogenesis. A great deal of both academic and commercial research has focused on the mechanisms by which Abeta is generated. However, investigations into the mechanisms underlying Abeta clearance have blossomed over the last several years. This minireview will summarize pathways involved in the removal of cerebral Abeta, including enzymatic degradation and receptor-mediated efflux out of the brain.

References

May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
Feb 27, 2001·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·A J TurnerD Coates
May 26, 2001·Science·N IwataT C Saido
Oct 31, 2001·Neuron·D J Selkoe
May 29, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ashley I Bush, Rudolph E Tanzi
Mar 14, 2003·Proceedings of the National Academy of Sciences of the United States of America·Wesley FarrisSuzanne Guenette
Oct 7, 2003·The Journal of Biological Chemistry·Eun-Suk SongLouis B Hersh
Nov 18, 2003·The Journal of Clinical Investigation·Joachim Herz
Feb 7, 2004·Human Molecular Genetics·Lars Bertram, Rudolph E Tanzi
May 14, 2004·Journal of Neurochemistry·Berislav V Zlokovic

❮ Previous
Next ❯

Citations

May 13, 2008·Cellular and Molecular Life Sciences : CMLS·E MalitoW-J Tang
Dec 8, 2009·Brain Structure & Function·Kanae Iijima-Ando, Koichi Iijima
Apr 27, 2012·Inflammopharmacology·G Joseph BroussardGloria J Klapstein
Sep 29, 2009·Journal of Bioenergetics and Biomembranes·Anna ColellJosé C Fernández-Checa
Jun 11, 2008·Neuromolecular Medicine·Esther S OhStina M Fangmark Tucker
Jul 16, 2008·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Berislav V Zlokovic
Dec 23, 2008·Nature Cell Biology·Robert D BellBerislav V Zlokovic
Apr 7, 2007·Nature Medicine·Markus Britschgi, Tony Wyss-Coray
Aug 24, 2005·Nature Medicine·Zhenhua WuBerislav V Zlokovic
Aug 19, 2007·Nature Medicine·Abhay SagareBerislav V Zlokovic
Mar 26, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Luis EscribanoDiana Frechilla
Mar 23, 2006·Nature Reviews. Neuroscience·Mark P Mattson, Tim Magnus
Apr 28, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sandra GrauMichael Ehrmann
May 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Doo-Sup ChoiRobert O Messing
Nov 23, 2006·Proceedings of the National Academy of Sciences of the United States of America·Martin J SadowskiThomas Wisniewski
Jun 19, 2008·Proceedings of the National Academy of Sciences of the United States of America·J Steven JacobsenMenelas N Pangalos
Jul 16, 2008·Proceedings of the National Academy of Sciences of the United States of America·Marie Neant-FeryMalcolm A Leissring
Feb 7, 2012·Proceedings of the National Academy of Sciences of the United States of America·Neha SehgalVijayalakshmi Ravindranath
Oct 2, 2012·The Journal of Biological Chemistry·Chao WangLi Gan
Jun 30, 2009·Antioxidants & Redox Signaling·Montserrat MaríJosé C Fernández-Checa
Sep 10, 2011·Antioxidants & Redox Signaling·Louise HedskogMaria Ankarcrona
Oct 8, 2009·Human Molecular Genetics·Lars Bertram, Rudolph E Tanzi
May 20, 2011·Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society·Lloyd M CuzzoAlfredo A Sadun
Jun 8, 2012·Cold Spring Harbor Perspectives in Medicine·Takaomi Saido, Malcolm A Leissring
Dec 31, 2005·Neuropathology : Official Journal of the Japanese Society of Neuropathology·Marion Maat-SchiemanSjoerd van Duinen
Nov 27, 2008·The Journal of Clinical Investigation·Rashid DeaneBerislav V Zlokovic
Jan 6, 2009·BMC Neuroscience·Valérie VingtdeuxPhilippe Marambaud
Jul 12, 2011·Fluids and Barriers of the CNS·Crissey L PascaleGerald D Silverberg
Jul 5, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Raja BhattacharyyaDora M Kovacs
May 22, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anna FernándezAnna Colell
Feb 21, 2006·NeuroRx : the Journal of the American Society for Experimental NeuroTherapeutics·J Steven JacobsenMenelas N Pangalos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.